
“Why Regeneron’s Price Could Soon Break Out: A Compelling Case for Investors”
Regeneron: A Promising Stock for Long-Term Investors Introduction On February 4, Regeneron released financial results for the fourth quarter of 2024, which beat my and Wall Street analysts’ expectations. The main contributors to its revenue and operating income growth were Dupixent and Libtayo, which were able to minimize the decline in demand for Eylea in…